1501 Stock Overview
Shanghai INT Medical Instruments Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Shanghai INT Medical Instruments Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$27.10 |
| 52 Week High | HK$32.00 |
| 52 Week Low | HK$24.65 |
| Beta | 0.16 |
| 1 Month Change | -2.34% |
| 3 Month Change | -6.23% |
| 1 Year Change | -1.81% |
| 3 Year Change | 19.65% |
| 5 Year Change | -13.97% |
| Change since IPO | 0.37% |
Recent News & Updates
Recent updates
Be Wary Of Shanghai Kindly Medical Instruments (HKG:1501) And Its Returns On Capital
Jul 14
Shanghai Kindly Medical Instruments' (HKG:1501) Shareholders Will Receive A Smaller Dividend Than Last Year
May 17Returns On Capital At Shanghai Kindly Medical Instruments (HKG:1501) Paint A Concerning Picture
Nov 26Shanghai Kindly Medical Instruments (HKG:1501) Is Reinvesting At Lower Rates Of Return
Aug 16Some Investors May Be Worried About Shanghai Kindly Medical Instruments' (HKG:1501) Returns On Capital
Apr 24Shareholders Are Loving Shanghai Kindly Medical Instruments Co., Ltd.'s (HKG:1501) 1.0% Yield
Apr 05What Is The Ownership Structure Like For Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?
Mar 15Declining Stock and Decent Financials: Is The Market Wrong About Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501)?
Jan 28Here's Why I Think Shanghai Kindly Medical Instruments (HKG:1501) Might Deserve Your Attention Today
Dec 28
Is Shanghai Kindly Medical Instruments Co., Ltd. (HKG:1501) Popular Amongst Insiders?
Dec 02Shareholder Returns
| 1501 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -6.4% | -3.0% | -0.9% |
| 1Y | -1.8% | -27.7% | 19.2% |
Return vs Industry: 1501 exceeded the Hong Kong Medical Equipment industry which returned -27.7% over the past year.
Return vs Market: 1501 underperformed the Hong Kong Market which returned 19.2% over the past year.
Price Volatility
| 1501 volatility | |
|---|---|
| 1501 Average Weekly Movement | 7.1% |
| Medical Equipment Industry Average Movement | 9.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 18.7% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 1501 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1501's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 1,727 | Dongke Liang | www.int-medical.com |
Shanghai INT Medical Instruments Co., Ltd. engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. The company offers digital inflation devices; cardiac valves balloon inflation catheter; guiding catheter used to provide a channel for introducing balloon catheter, guidewire or other treatment devices; micro catheter to support the placement of guide wires; guidewire; angiography catheter used to inject and infuse contrast media and fluid; Y-connector pack used in PTCA surgery; inflation device used to inflate the balloon of dilating the vessel or placing the stent in the vessel; manifold for single use; and manifold kit.
Shanghai INT Medical Instruments Co., Ltd. Fundamentals Summary
| 1501 fundamental statistics | |
|---|---|
| Market cap | HK$4.77b |
| Earnings (TTM) | HK$178.04m |
| Revenue (TTM) | HK$857.68m |
26.8x
P/E Ratio5.6x
P/S RatioIs 1501 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1501 income statement (TTM) | |
|---|---|
| Revenue | CN¥805.39m |
| Cost of Revenue | CN¥320.91m |
| Gross Profit | CN¥484.49m |
| Other Expenses | CN¥317.31m |
| Earnings | CN¥167.18m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.95 |
| Gross Margin | 60.16% |
| Net Profit Margin | 20.76% |
| Debt/Equity Ratio | 3.0% |
How did 1501 perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield27%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 19:26 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Shanghai INT Medical Instruments Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | CMB International Securities Limited |
| Yu Wu | CMB International Securities Limited |
| Xin Qiu Lin | Guoyuan Securities (HK) Ltd |